Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer

MLA

Versteijne, E., et al. “Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer.” Journal of Clinical Oncology, vol. 38, no. 16, June 2020, pp. 1763–73. EBSCOhost, https://doi.org/10.1200/jco.19.02274.

APA

Versteijne, E., Suker, M., Groothuis, K., Akkermans-Vogelaar, J. M., Besselink, M. G., Bonsing, B. A., Buijsen, J., Busch, O. R., Creemers, G. J. M., Dam, R. M. van, Eskens, F. A. L. M., Festen, S., Groot, J. W. B. de, Koerkamp, B. G., Hingh, I. H. de, Homs, M. Y. V., Hooft, J. E. van, Kerver, E. D., Luelmo, S. A. C., … Dutch Pancreatic Canc Grp. (2020). Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer. Journal of Clinical Oncology, 38(16), 1763–1773. https://doi.org/10.1200/jco.19.02274

Chicago

Versteijne, E., M. Suker, K. Groothuis, J.M. Akkermans-Vogelaar, M.G. Besselink, B.A. Bonsing, J. Buijsen, et al. 2020. “Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer.” Journal of Clinical Oncology 38 (16): 1763–73. doi:10.1200/jco.19.02274.